The new generic products which were recently developed. Volunteer will receive a single dose of Rivaroxaban Immediate Release tablet 10 mg with 250 mL of drinking water.,The marketed original products

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban Immediate Release tablet 20 mg, manufactured by Cadila Healthcare Limited, India relative to Xarelto in healthy Thai volunteers under fed condition

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban IR tablet 10 mg, manufactured by Cadila Healthcare Limited, India relative to Xarelto in healthy Thai volunteers under fasting condition